The dissemination of information to generalists compared to specialists is complicated.[12] Two studies found specialists were more likely to adopt COX-2 drugs before the drugs were recalled by the FDA.[13][14] One of the studies went on to state "using COX-2s as a model for physician adoption of new therapeutic agents, specialists were more likely to use these new medications for patients likely to benefit but were also significantly more likely to use them for patients without a clear indication".[14] Similarly, a separate study found that specialists were less discriminating in their choice of journal reading.[15]